Download video

Dr. Dreicer on Resistance to Antiandrogen Therapy in Prostate Cancer

269 views

OncLive

8 years ago

Dr. Dreicer on Resistance to Antiandrogen Therapy in Prostate Cancer

Dr. Dreicer on Resistance to Antiandrogen Therapy in Prostate Cancer

Dr. Dreicer on Resistance to Antiandrogen Therapy in Prostate Cancer
1:09
Dr. Dreicer on Resistance to Antiandrogen Therapy in Prostate Cancer
by OncLive
Dr. Dreicer on Developing Next-Generation Anti-Androgen Therapies for CRPC
0:57
Dr. Dreicer on Developing Next-Generation Anti-Androgen Therapies for CRPC
by Targeted Oncology
Dr. Dreicer on Future Treatment Approaches in Prostate CancerDreicer
0:50
Dr. Dreicer on Future Treatment Approaches in Prostate CancerDreicer
by OncLive
Dr. Robert Dreicer on Sequencing Therapies in Prostate Cancer
1:18
Dr. Robert Dreicer on Sequencing Therapies in Prostate Cancer
by OncLive
Dr. Dreicer on Prostate Cancer Combination Therapy
1:09
Dr. Dreicer on Prostate Cancer Combination Therapy
by OncLive
Dr. Dreicer on Abiraterone and Enzalutamide in Prostate Cancer
1:14
Dr. Dreicer on Abiraterone and Enzalutamide in Prostate Cancer
by OncLive
Dr. Robert Dreicer Discusses Sequencing MDV3100 and Abiraterone
1:02
Dr. Robert Dreicer Discusses Sequencing MDV3100 and Abiraterone
by OncLive
Dr. Robert Dreicer on Potential Combinations in Prostate Cancer
0:52
Dr. Robert Dreicer on Potential Combinations in Prostate Cancer
by OncLive
Dr. Robert Dreicer on Utilizing New Prostate Cancer Therapies
1:01
Dr. Robert Dreicer on Utilizing New Prostate Cancer Therapies
by OncLive
Dr. Dreicer on Trial Endpoints in Prostate Cancer
0:49
Dr. Dreicer on Trial Endpoints in Prostate Cancer
by OncLive
Dr. Dreicer on the Current Role of Abiraterone and Enzalutamide in Prostate Cancer
1:12
Dr. Dreicer on the Current Role of Abiraterone and Enzalutamide in Prostate Cancer
by OncLive
Dr. Dreicer on Ongoing Trials in Prostate Cancer
0:57
Dr. Dreicer on Ongoing Trials in Prostate Cancer
by OncLive
Dr. Robert Dreicer on Overcoming Resistance Pathways in mCRPC
1:50
Dr. Robert Dreicer on Overcoming Resistance Pathways in mCRPC
by OncLive
Optimizing Outcomes in Advanced Prostate Cancer
57:07
Optimizing Outcomes in Advanced Prostate Cancer
by ClevelandClinicCME
Dr. Antonarakis on AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
1:20
Dr. Antonarakis on AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
by Targeted Oncology
Dr. Dreicer on Combinations and Sequencing Agents With Immunotherapies in Prostate Cancer
0:53
Dr. Dreicer on Combinations and Sequencing Agents With Immunotherapies in Prostate Cancer
by OncLive
Dr. Dreicer on the Optimal Use of Radium-223 in Prostate Cancer
0:51
Dr. Dreicer on the Optimal Use of Radium-223 in Prostate Cancer
by OncLive
Dr. Dreicer Examines Prostate Cancer Advances From the Past 10 Years
1:28
Dr. Dreicer Examines Prostate Cancer Advances From the Past 10 Years
by OncLive
The relationship between prostate cancer treatment efficacy, survival and race | Robert Dreicer
3:17
The relationship between prostate cancer treatment efficacy, survival and race | Robert Dreicer
by Medicine Matters oncology
Dr. Dreicer Comments on Trial Endpoints in Prostate Cancer
1:01
Dr. Dreicer Comments on Trial Endpoints in Prostate Cancer
by Targeted Oncology